Carboplatin Injection, Solution
Product Images NDC 0703-4239

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carboplatin (NDC 0703-4239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Carboplatin Injection Solution A077269 1)

FDA Label Image

Carton 50 mg/5 mL (Carboplatin Injection Solution A077269 2)

Carton 50 mg/5 mL (Carboplatin Injection Solution A077269 2)
This is a description of a medication called CARBOplatin in an injection form. It comes in a 5 mL Multi-Dose Vial with a concentration of 50 mg/5 mL (10 mg/mL). The solution is sterile and for intravenous use as a cytotoxic agent. It is manufactured by Pharmachemie B.V. in the Netherlands for TEVA PHARMACEUTICALS USA, INC. The medication does not contain preservatives and should be stored at 20° to 25°C. Pharmacies are instructed to dispense it with the attached patient information leaflet. The bottom panel of the vial contains the lot number and expiration date. Full directions for use can be found in the accompanying package insert.*
FDA Label Image

Carton 150 mg/15 mL (Carboplatin Injection Solution A077269 3)

Carton 150 mg/15 mL (Carboplatin Injection Solution A077269 3)
This is a label with detailed information about a medication called CARBOplatin. It is an injection in a 15 mL multi-dose vial with a concentration of 10 mg/mL. The solution is sterile and intended for intravenous use as a cytotoxic agent. The medication should be stored at 20° to 25°C, protected from light, and retained in the carton until use. The label includes the manufacturer details, lot number, expiration date, as well as instructions for the pharmacist to dispense the medication along with a patient information leaflet. Each mL of the solution contains 10 mg of carboplatin and 10 mg of mannitol in water for injection. The package insert should be consulted for complete directions for use.*
FDA Label Image

Carton 450 mg/45 mL (Carboplatin Injection Solution A077269 4)

Carton 450 mg/45 mL (Carboplatin Injection Solution A077269 4)
This text provides information about a medication called CARBOplatin Injection. It includes details such as dosage, concentration, storage instructions, manufacturer information, and a reminder to dispense with an attached patient information leaflet. The medication is a sterile, aqueous solution for intravenous use, containing 10 mg/mL of carboplatin and 10 mg/mL of mannitol. Additionally, it states that the solution is a cytotoxic agent and should be stored at controlled room temperature. The manufacturer is Pharmachemie B.V. located in the Netherlands, and the product is manufactured for Teva Pharmaceuticals USA, Inc.*
FDA Label Image

Carton 600 mg/60 mL (Carboplatin Injection Solution A077269 5)

Carton 600 mg/60 mL (Carboplatin Injection Solution A077269 5)
This text appears to be a label or package insert for a medication called CARBOplatin Injection, which is a cytotoxic agent used intravenously. It is supplied in a 60mL Multi-Dose Vial with a concentration of 600 mg/60mL (10 mg/mL). The medication is manufactured in the Netherlands by Pharmachemie B.V. for Teva Pharmaceuticals USA, Inc. It is important to store the medication at a controlled room temperature and protect it from light. The package insert contains information on the composition of the injection and instructions for use. Pharmacies are advised to dispense the medication with an attached patient information leaflet.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.